Fusen Pharmaceutical Company Limited (stock code: 01652) published its monthly return for the period ended 31 October 2025. Authorized share capital remained at HKD 20,000,000, comprising 2,000,000,000 ordinary shares with a par value of HKD 0.01 each.

The total issued share capital also remained unchanged at 739,301,000 ordinary shares, without any movement in treasury shares. No new shares were issued or canceled during October 2025.

Under a share option scheme adopted on 14 June 2018 and granted on 19 July 2019, 16,000,000 options were outstanding at a monthly close, each with an exercise price of HKD 3.098. No new shares were issued under that scheme during the month, with 80,000,000 shares authorized under future option grants. No warrants, convertibles, or other agreements to issue additional shares were disclosed for October 2025.